BNET Industries
Masimo is in the Health Care Industry
Latest News and Analysis
Masimo Announces LNCS(TM) & LNOP(R)v Sensors Expanding Clinician Choice
Masimo, the inventor of Read-Through Motion & Low Perfusion Pulse Oximetry, today announced the dramatic expansion of Masimo's sensor offering with the introduction of LNCS and LNOPv sensor series. With LNCS and LNOPv, Masimo's customers will have access to well over 40 adhesive, reusable, ResposableTM and specialty sensors-including the...
Research Presented at the 2004 American Society of Anesthesiologists Conference Finds New Uses for Masimo SET Perfusion Index and Validates the Clinical Value of Masimo SET TC-I Ear Sensor
Research presented at the 2004 American Society of Anesthesiologists ASA conference in Las Vegas, NV, October 24-26, included two studies on new clinical applications of Masimo SET perfusion index and in another study hailed the clinical value of the Masimo SET TC-I Ear sensor. Also at the conference, three...
Masimo Will Introduce Two New Specialty Sensors at the NANN Conference: The Blue Cyanotic Sensor and the Hi-Fi Trauma Sensor
Masimo, the innovator of Signal Extraction Pulse Oximetry, today announced that it will debut two breakthrough Low Noise Optical Probe Specialty sensors at the NANN conference on October 13 in Orlando, Florida. The new LNOP Specialty sensors were designed to give clinicians maximum accuracy and reliability in difficult-to-monitor...
Masimo Introduces LNOP TC-I Arterial Blood-Oxygen, Perfusion Index and Pulse Rate Sensor to Bring Improved Monitoring to the Bedside
Irvine, Calif.-based Masimo, the innovator of Signal Extraction Pulse Oximetry today announced the introduction of the LNOP TC-I ear pulse oximetry sensor. The sensor, used to record a patient's blood-oxygen level, pulse rate and perfusion index, was developed with feedback from The Cleveland Clinic, ranked as one of the nation's...
Adaptive Probe Off Detection Technology (APOD)
APOD is a suite of complex and powerful signal processing algorithms that carefully analyze the incoming signal to determine if the pulse oximeter sensor is on or off the patient. Adaptive Probe Off Detection APOD delivers enhanced protection against erroneous pulse rate and arterial oxygen saturation readings when a sensor...
Evaluation of a New Reflectance Forehead Sensor in Detecting Oxygen Desaturation in Patients Undergoing Polysomnography
Pulse oximetry provides a critical parameter in the diagnosis and treatment of sleep apnea. This group of researchers has studied Masimo SET pulse oximetry in the past and found it to have better fidelity for Sleep-Disordered Breathing testing as compared to Nellcor pulse oximetry. In this study, these researchers wanted...
Cost Reduction Following Conversion to Masimo SET Pulse Oximetry - Experience in the Neonatal ICU
This study evaluates the financial impact of converting to Masimo SET pulse oximetry technology in the NICU. Masimo Corporation (Irvine, CA.) has introduced innovations in sensor design and technology that claim to increase the durability and longevity for sensors. This clinician evaluated these changes in sensor performance and the cost...
Multicenter Trial of Neonatal Pulse Oximeter Sensor Usage: a Difference Between Manufacturers
Pulse oximetry is routine for monitoring oxygenation in neonates. If the pulse oximeter sensor is designated for single-patient use and it is short-lived, the cost of monitoring can be high. Since pulse oximetry monitoring of sick newborns is often lengthy, the use of long-lived sensors would benefit the management and...
Additional Resources
BellwetherReport.com Analyst Report on COMS, MASI, SHLD and AMSC
BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have once again scheduled interviews with a...
Masimo Reports Second Quarter 2008 Financial Results
Record results mark 20th consecutive quarter of revenue growth Q2 2008 Highlights: * Product revenues increased 30% to a record $61.9 million * Direct (Non-OEM) Business revenues increased by 46% * Shipped 29,000 new pulse oximeters and Pulse CO-Oximeters IRVINE, Calif., Aug. 4 ...
First Nursing Facility Installation of Masimo Patient SafetyNet™ Goes Live With 'Remarkable' Results
State-of-the-art, remote monitoring and clinician notification system helps keep nursing facility patients safe and clinicians happy IRVINE, Calif., June 26 /PRNewswire-FirstCall/ -- Masimo , the inventor of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today announced the first installation of the Masimo Patient SafetyNet remote...
Examine the World Pulse Oximeters Market
Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. World Pulse Oximeters Market http://www.reportlinker.com/p090661/World-Pulse-Oximeters-Market.html This report analyzes the worldwide markets for Pulse Oximeters in Thousands of US$. The major types of Pulse Oximeters analyzed...
Mergent, Inc. Announces Quarterly Rebalancing of HealthShares™ Indexes
NEW YORK, June 17 /PRNewswire/ -- Mergent, Inc., administrator for the HealthSharesTM Indexes, a series of 20 underlying indexes for the HealthSharesTM Exchange Traded Funds, today announced the quarterly rebalancing of the Indexes. The following securities will be added and deleted in the Indexes effective before...
Mergent, Inc. Announces Changes to the HealthShares™ Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardiology and Neuroscience Indexes
NEW YORK, May 6 /PRNewswire/ -- Mergent, Inc., administrator for the HealthsharesTM Indexes, a series of 20 underlying indexes for the HealthSharesTM Exchange Traded Funds, today announced the following changes with effect from the opening of trade on Friday, May 9, 2008: Masimo Corporation will replace Millennium Pharmaceuticals...
Masimo to Present at Citi Investment Research 5th Annual Small & Mid-Cap Conference
IRVINE, Calif., March 14 /PRNewswire-FirstCall/ -- Masimo Corporation , the inventor of Pulse CO-Oximetry and Measure-Through Motion & Low Perfusion pulse oximetry, today announced that it is scheduled to present at the Citi Investment Research 5th Annual Small & Mid-Cap Conference at The Four Seasons Hotel in Las Vegas,...
Current Review for Masimo Corporation.
M2 PRESSWIRE-27 February 2008-The SI Report: Current Review for Masimo CorporationC1994-2008 M2 COMMUNICATIONS LTD RDATE:27022008 Streetinvesting.com has now resumed our progressive review of Masimo Corporation (Nasdaq: MASI) after it traded up 7% Wednesday, early in the morning with average...
Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results
Record results mark 18th consecutive quarter of revenue growth 2007 Highlights: * Product revenues increased 29% to a record $199.7 million * Masimo SET pulse oximeter units increase 20% to 116,300 units IRVINE, Calif., Feb. 26 /PRNewswire-FirstCall/ -- Masimo Corporation ,...
Masimo to Report Fourth Quarter and Fiscal Year 2007 Financial Results on February 26, 2008
Conference call and webcast with Masimo to begin at 2:00 pm PT (5:00 pm ET) IRVINE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Masimo Corporation , the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, today announced it will release fourth quarter and fiscal year...
National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM)
To: BUSINESS EDITORS Contact: Dana Banks of Masimo Corporation, +1-949-297-7348 IRVINE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Masimo (Nasdaq:MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motionand Low Perfusion pulse oximetry, announced today that the NationalFire Protection Association NFPA has included Carbon Monoxide COscreening by Pulse CO-Oximetry as part of...
Pulse CO-oximetry monitor.(PRODUCT SHOWCASE: Monitoring Systems)
[ILLUSTRATION OMITTED] In addition to the ability to provide accurate pulse oximetry (Sp[O.sub.2]) readings in situations of motion and low perfusion, the Masimo Rainbow SET Pulse CO-Oximetry platform has recently been expanded to continuously and noninvasively monitor the level of carboxyhemoglobin SpCO...
- Next »
- page 1 of 1
- « Previous
Sort byClose
View by Content TypeClose
Masimo Company Info
NAICS Code
Surgical and Medical Instrument Manufacturing: 339112
